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Abstract
Background: Mouse strains with a contrasting response to morphine provide a unique model for
studying the genetically determined diversity of sensitivity to opioid reward, tolerance and
dependence. Four inbred strains selected for this study exhibit the most distinct opioid-related
phenotypes. C57BL/6J and DBA/2J mice show remarkable differences in morphine-induced
antinociception, self-administration and locomotor activity. 129P3/J mice display low morphine
tolerance and dependence in contrast to high sensitivity to precipitated withdrawal observed in
SWR/J and C57BL/6J strains. In this study, we attempted to investigate the relationships between
genetic background and basal gene expression profile in the striatum, a brain region involved in the
mechanism of opioid action.
Results: Gene expression was studied by Affymetrix Mouse Genome 430v2.0 arrays with probes
for over 39.000 transcripts. Analysis of variance with the control for false discovery rate (q < 0.01)
revealed inter-strain variation in the expression of ~3% of the analyzed transcripts. A combination
of three methods of array pre-processing was used to compile a list of ranked transcripts covered
by 1528 probe-sets significantly different between the mouse strains under comparison. Using
Gene Ontology analysis, over-represented patterns of genes associated with cytoskeleton and
involved in synaptic transmission were identified. Differential expression of several genes with
relevant neurobiological function (e.g. GABA-A receptor alpha subunits) was validated by
quantitative RT-PCR. Analysis of correlations between gene expression and behavioural data
revealed connection between the level of mRNA for K homology domain containing, RNA binding,
signal transduction associated 1 (Khdrbs1) and ATPase Na+/K+ alpha2 subunit (Atp1a2) with
morphine self-administration and analgesic effects, respectively. Finally, the examination of
transcript structure demonstrated a possible inter-strain variability of expressed mRNA forms as
for example the catechol-O-methyltransferase (Comt) gene.
Conclusion: The presented study led to the recognition of differences in the gene expression that
may account for distinct phenotypes. Moreover, results indicate strong contribution of genetic
background to differences in gene transcription in the mouse striatum. The genes identified in this
work constitute promising candidates for further animal studies and for translational genetic
studies in the field of addictive and analgesic properties of opioids.
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Background
The presence of strong genetic determinants of locomotor
and analgesic response to morphine and heroin in mice
was first observed more than thirty years ago [1-5]. Behav-
ioural phenotyping of a large panel of commonly used
inbred strains of mice showed tremendous diversity in the
response to both acute and prolonged opioid treatments
[6-9]. Strain surveys demonstrated that sensitivity to mor-
phine is to a great degree dependent on genetic determi-
nants. Based on a number of previous studies, we have
chosen for gene expression studies four inbred mouse
strains (129P3/J, SWR/J DBA/2J and C57BL/6J) with the
clearest differences in opioid-related phenotypes. The
129P3/J strain failed to develop tolerance to morphine-
induced analgesia [8] or physical dependence, as evi-
denced by the lack of withdrawal symptoms [9]. Unusual
sensitivity to precipitated withdrawal [9] with extremely
low morphine oral self-administration was observed in
SWR/J mice [6,9]. In marked contrast, the C57BL/6J strain
was found to have the highest level of oral morphine con-
sumption [6]. However, sensitivity to the reinforcing
effects of morphine in conditioned place preference and
intravenous self-administration paradigms was higher in
DBA mice than in C57BL [10]. The two frequently used
laboratory strains of mice C57BL/6J and DBA/2J show
remarkable differences in analgesic response to mor-
phine. Moreover, several studies have reported profound
differences in morphine induced locomotor activity
between the sensitive C57BL/6 and insensitive DBA/2
mice [3,7].
Opioids are known to act through binding to μ-opioid
receptor, which is located on GABAergic interneurons in
the ventral tegmental area (VTA) and substantia nigra
(SN). Mechanisms which underlie opioid actions depend
on activation of dopaminergic midbrain neurons, result-
ing in an increased dopamine release in the mesocorticol-
imbic structures such as ventral and dorsal striatum [11].
The striatum, a brain region that contains high level of
opioid receptors, is a major neural substrate for the loco-
motor and reinforcing effects of opioids [12,13]. Conse-
quently, it is accepted that the nucleus accumbens, a
region of the ventral striatum, which receives projections
from the VTA, is involved in the processes of reward stim-
ulus-response learning [14,15]. The dorsal part of the
striatum, caudate-putamen, is an integral component of
reward circuitry responsible for the control of motivated
and motor behaviour [16,17]. The behavioural effects of
opioids are associated with altered gene expression in the
striatum. A single injection of morphine alters striatal
expression of some genes in mice, including immediate
early genes as well as transcription of cytoskeleton-related
genes and proteins involved in oxidative chain [18,19].
Therefore, mechanisms that manage striatal gene expres-
sion may be implicated as important mediators in the
prolonged behavioural effects of opioid administration.
Elucidation of molecular mechanisms essential for action
of opioids is a crucial step forward in our understanding
of such phenomena as opiate reward and addiction.
Here, we have focused on the identification of the
genomic factors responsible for the extreme behavioural
differences outlined above. Gene expression profiles in
various inbred mouse strains were previously established
in multiple brain regions [20-24]. Specific genes involved
in mediating the differences in running wheel activity
were identified by comparing gene expression profiles in
the striatum of four inbred strains (C3H/HeSnJ, 129/
SvEv, C57BL/6J and 129/B6F2) [25]. Furthermore, striatal
gene expression of quasi-congenic strains and their pro-
genitors C57BL/6By and BALB/cJ were previously
described and basal expression of aldehyde dehydroge-
nase genes (Aldh1a1 and Aldh7a1) was suggested as the
factor implicated in alcohol preference [26]. Correlation
of the gene expression data with neurophenotypes across
inbred strains was proposed as a method for identifying
candidate genes for behavioural traits such as the level of
anxiety or aggressiveness [21,24]. The combination of glo-
bal gene expression and mapping analysis using recom-
binant inbred strains provided a method for identifying
quantitative trait genes underlying complex traits [27,28].
Multidisciplinary results integrated in the WebQTL data-
base give an opportunity to identify expression of quanti-
tative trait loci that underlie phenotype and regulate
expression of the genes selected by microarrays [29]. For
example, using genetic correlation analysis and pheno-
type database, a positive correlation between D2
dopamine receptor (Drd2) expression and preference for
ethanol and saccharin, as well as its negative correlation
with ethanol-induced locomotor activity were found [28].
Our goal in this study was to recognize functional classes
of genes and individual candidates involved in the mech-
anisms underlying susceptibility to the opioid actions.
The gene expression profiling in combination with bioin-
formatic approach paves the way for investigation of
genes that contribute to neurobehavioral phenotypes.
Apart from diversity in the level of mRNA for a great
number of genes, also differences in the appearance of
putative transcript forms between the inbred mouse
strains were found. The present results form the basis for
further molecular and pharmacological research.
Results
1. Microarray data analysis
Five independent biological replicates of microarray were
prepared for each strain of mice. To minimize the influ-
ence of potential individual differences between the ani-
mals and technical variation introduced by tissue
preparation and dissection, total RNA isolated from theBMC Genomics 2006, 7:146 http://www.biomedcentral.com/1471-2164/7/146
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striatum of three animals was pooled. Each pool of total
RNA was separately converted to cRNA and hybridized to
a single microarray (Figure 1). Microarray replicates were
very similar: the Pearson's product-moment correlation
coefficient among the arrays ranged between: 0.98–0.99
for 129P3/J, 0.97–0.99 for C57BL/6J, 0.97–0.99 for DBA/
2J and 0.98–0.99 for SWR/J (using results from PDNN
normalization method, see below). The data was pre-
processed to correct for systematic differences between the
arrays. There is still no standard protocol for pre-process-
ing of Affymetrix array data. However, the process of nor-
malization has a profound influence on detection of
differentially expressed genes. Results from three widely
acceptedalternative methods:PDNN (Position-Depend-
ent Nearest Neighbor), RMA (Robust Multichip Analysis)
and MBEI (Model-Based Expression Index) were used for
further analysis. The above-mentioned methods use dif-
ferent algorithms and assumptions so they produce differ-
ent estimates of transcripts abundance. RMA provides
statistically robust averaging methods, MBEI is the
weighted average of PM/MM differences and PDNN fits a
model that allows sequence-specific binding affinities and
nearest-neighbor stacking interactions. Pairwise Pearson's
correlation coefficient of expression level between meth-
ods ranged from 0.89 (PDNN and RMA) to 0.82 (PDNN
and MBEI). The performed analysis takes into account the
level of agreement between the methods and promotes
transcripts with significant differences in all of them. The
final list of differentially expressed transcripts includes
1000 transcripts selected by all three methods, 454 tran-
scripts selected by at least two methods and only 74 tran-
scripts selected by one method.
2. Differences in gene expression in the striatum among 
the four inbred mouse strains
Gene expression values were filtered to remove probe-sets
with hybridization signal close to the background noise
level. The remaining resulting in 24.508 probe-sets
(54.3% of all probe-sets on the array) were taken into fur-
ther investigation. One-way ANOVA with the mouse
strain as the factor has generated p-value for each of the
24.508 probe-sets. Taking into account the fact that dur-
ing ANOVA, a dozen thousands of hypotheses are being
tested simultaneously, the q-value – method which pro-
vides a measure of statistical significance for each individ-
ual probe-set was used. Whereas the p-value is a measure
of significance in terms of the false positive rate, the q-
value is a measure in terms of the false discovery rate
(FDR). Here, FDR is the expected proportion of false pos-
itive results among all rejected hypotheses multiplied by
the probability of making at least one rejection [30]. The
threshold for a significant difference was set at three q-
value cut-offs (q < 0.01, q < 0.001, q < 0.0001) for results
obtained from the three different methods of array nor-
malization process (Figure 2). The list of differentially
expressed genes was established using similar approach as
the previously described level of agreement [31]. The
obtained results were used to create a rank for each probe-
set (see Methods). Differences between 21.972 (90%)
probe-sets did not reach the level of significance, while
344 (1.4%) probe-sets reached the highest rank. 1528
(6.2%) probe-sets reached at least rank 3 and were
selected for further bioinformatic analyses (Figure 2). The
probe-sets targeted 1460 different transcripts (~3% of
transcripts targeted by the array), including about 520
expressed sequence tags (ESTs). The complete list of
probe-sets is included in additional material (see Addi-
tional file 2).
3. Gene ontology analysis
Differentially expressed genes were investigated for puta-
tive cellular functions. Significantly over-represented
functional groups of genes were obtained from gene
ontology (GO) DAVID 2.1 database http://
david.abcc.ncifcrf.gov. Analysis of biological function of
genes whose expression differed between the strains
revealed over-representation of those related to protein
biosynthesis (42 genes) and carboxylic acid metabolism
(28 genes). Candidates genes with potential involvement
in the neuronal function were found among genes classi-
fied to over-represented groups linked to vesicle-mediated
transport (25 genes), microtubular cytoskeleton (31
genes) and synaptic transmission (15 genes). Further-
more, cellular localization of two other over-represented
Experimental design Figure 1
Experimental design. Biological replicates, sample pooling 
and validation of presented gene expression comparison of 
the four inbred mouse strains were performed using strategy 
described by the scheme. Five independent biological repli-
cates of microarray were prepared for each strain of mice. 
Total RNA isolated from the striatum of three animals was 
pooled. Each pool of total RNA was separately converted to 
cRNA and hybridized to a single microarray. Samples from 
two separate groups of animals from each strain of mice 
were used in qPCR experiment.
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groups of transcripts was linked to mitochondrion (64
genes) and to ribosome (22 genes) (Table 1).
Functional classification of strain-specific gene expression
profiles was also performed. Significant over-representa-
tion in C57BL/6J mice was found for three ontology
groups of genes were significantly over-represented,
including: cytoskeleton organization (11 genes) and neg-
ative regulation of cell organization (3 genes). Specific
functional groups associated with lipid metabolism (11
genes) and carboxylic acid metabolism (9 genes) were
found to be over-represented in DBA/2J. On the other
hand, genes connected with regulation of apoptosis (9
genes) were over-represented in SWR/J strain. Using uni-
form rigorous criteria for GO analysis, no over-repre-
sented functional classes for 129P3/J were found.
Detailed description of over-represented groups with gene
lists are in Table 2 and additional material (see Additional
file 3).
4. qPCR and analysis of multiple array probe-sets
Quantitative RT-PCR (qPCR) was performed on samples
from individual animals, and was used to verify the differ-
ential expression detected by microarrays. Five genes
(Atp1a2, Comt, Gabra1, Gabra2 and Syt4) were selected for
a qPCR experiment since they were linked by GO analysis
to synaptic transmission (GO:0007268). Group III
metabotropic glutamate receptor (Grm7) and a subunit of
G protein activated inward rectifier potassium channel
(Kcnj9) are also involved in neuronal transmission [32].
In addition, two cytoskeletal genes Gfap and Mtap2 were
selected due to evidences of their regulation upon chronic
morphine treatment [33,34]. Each qPCR assays target
mRNA sequence in the coding region (Table 3). To detect
Distribution of ranks according to the three methods of array pre-processing (PDNN, RMA and MBEI) Figure 2
Distribution of ranks according to the three methods of array pre-processing (PDNN, RMA and MBEI). Signifi-
cance of inter-strain differences is presented as a plot of logarithm of q-value versus expression level. Particular ranks are 
marked with colour as indicated on the left. Significance steps for ranks are marked with green horizontal lines. 1528 significant 
probe-sets are presented below as dots marked with light blue. Additionally, selected for qPCR genes were marked with yel-
low triangles with gene symbols (Atp1a2 – 1455136_at, Comt – 1418701_at, Gabra1 – 1436889_a, Gabra2 – 1455444_a, Grm7 – 
1459532_at, Kcnj9 – 1450712_at, Syt4 – 1415844_at, Gfap – 1440142_s_at, Mtap2 – 1440699_at, Hprt1 – 1448736_a_at).
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existence of alternative mRNA forms, signal intensity from
multiple probe-sets designed to detect the same transcript
was compared with qPCR results. To confirm biological
differences between the strains, additional qPCR experi-
ment was performed on independent RNA samples.
The qPCR method found a tendency to elevation of
expression level of the ATPase Na+/K+ transporting alpha
2 subunit (Atp1a2) transcript in C57BL/6J strain, what is
in agreement with the hybridization signal measured by
the probe-set 1452308_a_at covering parallel part of the
mRNA sequence as the Taqman probe used in qPCR.
However, the probe-set 1455136_at complementary to
deep 3' untranslated region of Atp1a2  mRNA showed
reverse profile with the lowest expression in C57BL/6J
mice. The results provide indication of alternative termi-
nation of the transcription in the C57BL/6J strain, associ-
ated with higher abundance of a putative short transcript
form (Figure 3B). Abundance of the potassium inwardly-
rectifying channel subfamily J member 9 (Kcnj9) mRNA
measured by microarrays was lower in C57BL/6J mice.
Results of two probe-sets designed to detect 5' exons of
Kcnj9 gene were filtered out during microarray analysis
due to weak hybridization signal. qPCR validation exper-
iment for Kcnj9 confirmed microarray results with a 2-fold
(p < 0.001) difference in the mRNA abundance (Figure
3A). Differences in the gene expression of two GABA-A
receptor subunits were confirmed using qPCR analysis.
GABA-A receptor alpha1 subunit (Gabra1) showed ~1.5-
fold higher abundance in the C57BL/6J strain (p < 0.05)
compared to DBA2/J strain. On the other hand, expres-
sion of GABA-A receptor alpha2 subunit (Gabra2) gene in
C57BL/6J strain showed opposite profile, with above 2-
fold (p < 0.001) lower level compared to the other strains
(Figure 3A). Signal from the microarray probe-set
1459532_at covering 3' region of metabotropic glutamate
receptor 7 (Grm7) was detected only in DBA/2J mice (Fig-
ure 3B). To verify transcript abundance we used fluoro-
genic PCR probe designed to anneal to exon 2. Grm7
expression measured by qPCR showed significantly
higher level in 129P3/J mice versus DBA/2J and SWR/J
strains (p < 0.01) (Figure 3A). However, results obtained
by independent qPCR experiment were not significant
(Table 3). Opposite profiles of hybridization signal from
two probe-sets of the catechol-O-methyltransferase gene
(Comt) 1449183_at (covering the last 2 exons) and
1418701_at (covering deep 3' untranslated region) were
found in C57BL/6J strain. qPCR method established Comt
transcript abundance to be the highest in C57BL/6J mice,
which is in agreement with the results for the probe-set
1449183_at covering the corresponding mRNA region (p
< 0.001). In summary, Comt expression level is about 2-
fold higher in C57BL/6J than in the other mouse strains,
though hypothetical longer transcript form is more abun-
Table 1: Functional classification of genes selected from microarray analysis.
GO Category GO Term (Term ID) Count #genes Significance p-value
Biological Process Protein Biosynthesis
(GO:0006412)
42 0.002
Biological Process Vesicle-Mediated Transport
(GO:0016192)
25 0.002
Biological Process Macromolecule Biosynthesis
(GO:0009059)
45 0.003
Cell Component Mitochondrion
(GO:0005739)
64 0.004
Biological Process Carboxylic Acid Metabolism
(GO:0019752)
28 0.004
Biological Process Cellular Protein Metabolism
(GO:0044267)
155 0.004
Cell Component Ribosome
(GO:0005840)
22 0.006
Biological Process Cytoskeleton Organization and Biogenesis
(GO:0007010)
31 0.007
Biological Process Cellular Lipid Metabolism
(GO:0044255)
28 0.007
Cell Component Small Ribosomal Subunit
(GO:0015935)
70 . 0 0 9
Biological Process Small Gtpase Mediated Signal Transduction
(GO:0007264)
21 0.010
Biological Process Synaptic Transmission
(GO:0007268)
15 0.010
Over-represented functional classes of genes among transcripts with different expression profiles between the mouse strains were found using 
DAVID 2.1 tool. Analysis were performed at level five and with default parameters which provide low coverage and relatively high specificity for 
detection of enriched terms. Over-represented GO groups were found at p ≤ 0.01 level Fisher exact test.BMC Genomics 2006, 7:146 http://www.biomedcentral.com/1471-2164/7/146
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dant in DBA/2J, 129P3/J and SWR/J strains (Figure 3B).
Gene expression level of synaptotagmin IV (Syt4) was
above 2-fold higher in C57BL/6J than in SWR/J strain (p
< 0.01) (Table 3). qPCR analysis did not find differences
in the level of glial fibrillary acidic protein (Gfap) and
microtubule-associated protein 2 (Mtap2) transcripts. The
differences in abundance of Gfap  and  Mtap2  observed
between the strains are likely to be restricted to specific
mRNA forms, represented on the array by the
1440142_s_at and 1440699_at probe-sets (Figure 4).
Comparison between the two qPCR experiments showed
significant (p < 0.0001) correlation coefficient with r =
0.92.
In order to inspect the intra-gene diversity, an interval
mapping tool from the WebQTL http://www.genenet
work.org database was used. The negative correlation
within probe-sets was observed for Atp1a2  (r = -0.95
between 1434893_at and 1455136_at) and Comt (r = -
0.80 between 1449183_at and 1418701_at). Identifica-
tion of possible cis- and trans-acting variations controlling
gene expression was performed using HBP/Rosen Stria-
tum M430v2 (April05) PDNN Clean dataset. The likeli-
hood ratio statistic (LRS) provides a measure of the
linkage between variation in the phenotype and genetic
differences at a particular genetic locus. Significant LRS
close to transcript position, which is an indication of cis-
acting variations (LRS > 32.2, LOD > 7), was found for
Atp1a2 (1434893_at, LRS = 65.48 and 1455136_at, LRS =
121.4),  Kcnj9  (1450712_at, LRS = 65.22), Comt
(1418701_at, LRS = 59.20 and 1449183_at, LRS = 44.95)
and Grm7 (1459532_at, LRS = 33.51). Trans-acting ele-
ments (LRS > 9.2, LOD > 2) that are involved in expres-
sion of six analysed genes were not identified (Figure 3C).
5. Correlation of gene expression and phenotype
To identify genes that are accountable for the variation in
response to morphine between the inbred mouse strains,
differences in expression of genes selected on the basis of
the microarray experiment were compared with pheno-
typic data. Expression values from 1528 microarray
probe-sets were correlated with the results of 1) voluntary
morphine consumption in two-bottle choice paradigm
(C57BL/6J>129P3/J>DBA/2J>SWR/J) and 2) percent of
maximal possible analgesic effects (% MPE) of 3.6 mg/kg
morphine measured by the hot-plate assay (129P3/
J>DBA/2J>SWR/J>C57BL/6J). Analysis resulted respec-
tively, in 219 and 69 probe-sets with Pearson's correlation
Table 2: Functional classification of strain-specific gene expression.
C57BL/6J
Biological Process Negative Regulation of Cell Organization and Biogenesis
(GO:0051129)
4< 0 . 0 0 1
Biological Process Regulation of Microtubule Polymerization or Depolymerization
(GO:0031110)
30 . 0 0 6
Biological Process Cytoskeleton Organization and Biogenesis
(GO:0007010)
11 0.008
Biological Process Cellular Lipid Metabolism
(GO:0044255)
10 0.010
DBA/2J
Biological Process Cellular Lipid Metabolism
(GO:0044255)
11 <0.001
Biological Process Carboxylic Acid Metabolism
(GO:0019752)
90 . 0 0 4
Cell Component Microbody
(GO:0042579)
50 . 0 0 5
Cell Component Peroxisome
(GO:0005777)
50 . 0 0 5
129P3/Ja
SWR/J
Biological Process Regulation of Apoptosis
(GO:0042981)
90 . 0 0 2
Biological Process Regulation of Programmed Cell Death
(GO:0043067)
90 . 0 0 2
Biological Process Negative Regulation of Programmed Cell Death
(GO:0043069)
90 . 0 0 9
a no significantly over-represented groups were found for 129P3/J strainBMC Genomics 2006, 7:146 http://www.biomedcentral.com/1471-2164/7/146
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Table 3: Gene expression results obtained by microarrays and qPCR.
Gene Affy ID PCR assay ID
(exon boundary)
Strain Microarray (MBEI)a (n = 5) qPCR Ib
(n = 6–9)
qPCR IIc
(n = 6)
1d 2
ATPase, Na+/K+ transporting, alpha 
2 polypeptide (Atp1a2)
(1)1427465_at
(2)1455136_at
Mm00617899_m1
(20/21)
C57 1.24 ± 0.08 0.52 ± 0.08 1.15 ± 0.07 1.19 ± 0.12
DBA 0.98 ± 0.07 1.39 ± 0.1 0.9 ± .0.06 0.96 ± 0.17
129 0.9 ± 0.06 1.08 ± 0.06 0.89 ± 0.1 0.83 ± 0.15
SWR 0.88 ± 0.07 1.02 ± 0.05 1.06 ± 0.09 0.98 ± 0.07
Catechol-O-methyltransferase 
(Comt)
1418701_at
Mm00514377_m1
(4/5)
C57 0.48 ± 0.08 1.48 ± 0.08 1.59 ± 0.06
DBA 1.17 ± 0.04 0.93 ± 0.05 0.9 ± 0.08
129 1.19 ± 0.07 0.89 ± 0.05 0.78 ± 0.07
SWR 1.16 ± 0.11 0.71 ± 0.09 0.76 ± 0.08
Gamma-aminobutyric acid receptor 
(GABA-A), subunit alpha 1 (Gabra1)
1436889_at
Mm00439040_m1
(2/3)
C57 1.09 ± 0.03 1.62 ± 0.1 1.46 ± 0.1
DBA 0.76 ± 0.02 0.74 ± 0.24 0.82 ± 0.04
129 1.09 ± 0.05 0.81 ± 0.31 0.96 ± 0.08
SWR 1.06 ± 0.04 0.83 ± 0.33 0.78 ± 0.03
Gamma-aminobutyric acid receptor 
(GABA-A), subunit alpha 2 (Gabra2)
(1)1443865_at
(2)1455444_at
Mm00433435_m1
(5/6)
C57 0.55 ± 0.06 0.57 ± 0.03 0.43 ± 0.07 0.26 ± 0.08
DBA 1.08 ± 0.11 1.09 ± 0.07 1.26 ± 0.09 1.13 ± 0.08
129 1.2 ± 0.07 1.21 ± 0.04 1.25 ± 0.08 1.31 ± 0.07
SWR 1.17 ± 0.07 1.13 ± 0.05 1.06 ± 0.1 1.05 ± 0.05
Glutamate receptor, metabotropic 
7 (Grm7)
1459532_at
Primers and probe sequence are 
available on request
(2)
C57 0.46 ± 0.14 1.09 ± 0.11 1.03 ± 0.13
DBA 2.86 ± 0.16 0.73 ± 0.13 0.66 ± 0.32
129 0.32 ± 0.14 1.46 ± 0.11 1.21 ± .013
SWR 0.36 ± 0.14 0.72 ± 0.18 1.00 ± 0.12
Potassium inwardly-rectifying 
channel, subfamily J, member 9 
(Kcnj9)
1450712_at
Mm00434623_m1
(3/4)
C57 0.42 ± 0.13 0.48 ± 
.0.08
0.51 ± 0.16
DBA 1.18 ± 0.12 1.23 ± 0.05 1.25 ± 0.11
129 0.94 ± 0.06 1.16 ± 0.07 1.15 ± .0.08
SWR 1.46 ± 0.11 1.13 ± 0.05 1.15 ± 0.08
Synaptotagmin IV (Syt4) 1415844_at
Mm00436870_m1
(1/2)
C57 1.33 ± 0.01 nte 1.51 ± 0.18
DBA 1.21 ± 0.07 nt 1.06 ± 0.03
129 0.71 ± 0.08 nt 0.86 ± 0.23
SWR 0.75 ± 0.06 nt 0.61 ± 0.13
Glial fibrillary acidic protein (Gfap) 1440142_s_at
Mm01253033_m1
(6/7)
C57 1.29 ± 0.09 1.29 ± 0.12 1.12 ± 0.08
DBA 0.78 ± 0.12 0.88 ± 0.11 0.88 ± 0.06
129 0.5 ± 0.07 0.7 ± 0.13 0.78 ± 0.11
SWR 1.43 ± 0.05 1.12 ± 0.07 1.14 ± 0.07
Microtubule-associated protein 2 
(Mtap2)
1440699_at
Mm00485230_m1
(3/4)
C57 0.62 ± 0.15 nt 0.94 ± 0.14
DBA 1.12 ± 0.05 nt 1.03 ± 0.21
129 1.22 ± 0.03 nt 1.19 ± 0.18
SWR 1.13 ± 0.05 nt 0.84 ± 0.26BMC Genomics 2006, 7:146 http://www.biomedcentral.com/1471-2164/7/146
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coefficient greater than |0.95| and p < 0.05. Furthermore,
WebQTL database was used to correlate differentially
expressed genes between BXD RI panel with the published
phenotypes [29]. As in the first analysis, voluntary mor-
phine consumption and % MPE (behavioural traits ID:
10469 and 10029) and expression results for the striatum
were taken into account. Significant correlation (p < 0.05)
and r > |0.5| with two morphine-related phenotypes was
found for 567 and 1055 probe-sets, respectively. Results
from both approaches overlapped for 10 (oral morphine
self-administration) and 6 (morphine analgesia) probe-
sets (Figure 5). The highest correlation with oral mor-
phine self-administration was found for K homology
domain containing, RNA binding, signal transduction
associated 1 (Khdrbs1, 1434541_x_at). Moreover, gene
expression of Gabra2 (1455444_at) was also found to be
correlated with oral morphine consumption. Expression
of Atp1a2 in the striatum was highly related to the analge-
sic potency of morphine (Figure 5). Moreover, the
observed differences in gene expression of Atp1a2 meas-
ured by different probe-sets (1427465_at and
1443823_a_at versus 1455136_at) had reverse relation to
the phenotype.
Discussion
In this study, we have focused on the comparison of tran-
scription profiles between four inbred strains of mice
markedly differing in their sensitivity to opioids. Differ-
ences in gene expression were compared in drug-naïve
animals to identify putative factors which may influence
susceptibility to opioid treatment. Recent studies have
described mouse strain specific gene expression profiles in
the whole brain as well as in the specific regions, like the
hippocampus, cerebellum, cortex or amygdala
[20,21,28,35,36]. Differential abundance of transcripts
was proposed to be an important factor implicated in
complex behavioural traits [25]. The obtained results indi-
cate broad differences in the transcription profile between
the inbred mouse strains under investigation. Differences
in the abundance of numerous transcripts, for example
Kif5b, Cap1, Pam, Gas5, Pttg1 [20], are in agreement with
the results presented in this report. Significant fraction of
differences in inter-strain gene expression is independent
of the brain region [35]. The presented disparity in the
global transcription profiles is similar to the value esti-
mated before (1–2% of all genes) [35]. In our case, the
experiment identified more than thousand transcripts dif-
fering in abundance between the strains. A large fraction
of transcripts, including nearly a half of expressed
sequence tags, has not been considered so far to be con-
nected with any specific brain function (including
enzymes of basal metabolism or components of immuno-
logical system). Thus, focusing only on a few dozens of
the most divergently expressed genes may lead to the situ-
ation when important factors involved in neurobehav-
ioural variability are ignored. Gene ontology (GO)
analysis was performed to identify biological themes
among differentially expressed genes. Functional GO
analysis showed over-representation of genes encoding
proteins involved in cytoskeleton organisation and vesi-
cle-mediated transport. That may provide partial explana-
tion for such between-strain differences as brain weight or
volume of the striatum [37]. Furthermore, expression of
mRNA for several cytoskeleton-related proteins in the
medial striatum of B6CBAF1/J mice was altered by acute
morphine administration [18]. The observed differences
in basal level of mRNA for cytoskeleton-related proteins
may affect structural organization of neurons. That might
be responsible for behavioural reactions to the first injec-
tion of morphine, which considerably differ between the
strains under analysis [1,7,9]. This is further substantiated
by the observation that in rats, chronic morphine admin-
istration changes the expression of several cytoskeleton-
related genes in the striatum [33]. A group of genes con-
nected with synaptic transmission was also identified by
GO analysis. A multitude of morphine effects indicates
that multiple neurotransmitter systems are involved in
formation of each behavioural profile. Genes encoding
two subunits of GABA-A receptor (Gabra1 and Gabra2)
showed significant differences in the expression between
the strains. Association of the expression of various GABA-
A receptor subunits with morphine self-administration
Hypoxanthine guanine 
phosphoribosyl transferase 1 
(Hprt1)
1448736_a_at
Mm00446968_m1
(6/7)
C57 1.03 ± 0.04 1.09 ± 0.09 1.1 ± 0.1
DBA 1.01 ± 0.03 1.02 ± 0.04 0.93 ± 0.08
129 1 ± 0.02 1 ± 0.08 1.02 ± 0.04
SWR 0.97 ± 0.04 0.9 ± 0.09 0.88 ± 0.11
Results are presented as fold change of average expression level across all the four mouse strains ± standard error of the mean. Results with fold 
change above 1.5 are bolded. Taqman used in qPCR experiments are described by assay ID and exon boundary.
a relative expression levels from probe-sets significantly different between the strains were obtained by using MBEI algorithm.
b qPCR I was carried out on individual samples used also for microarray hybridization
c qPCR II was performed on independent samples
d two genes (Atp1a2 and Gabra2) are represented by more than one probe-set.
e nt – gene was not tested
Table 3: Gene expression results obtained by microarrays and qPCR. (Continued)BMC Genomics 2006, 7:146 http://www.biomedcentral.com/1471-2164/7/146
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Analyses of gene expression of the six candidate genes by qPCR method (A), multiple probe-sets from the microarray (B) and  genome-wide interval mapping (C) Figure 3
Analyses of gene expression of the six candidate genes by qPCR method (A), multiple probe-sets from the 
microarray (B) and genome-wide interval mapping (C). A. Results of qPCR are presented as fold change of average 
expression level across all the four mouse strains. Transcript region covered by Taqman probe is marked in the scheme of 
transcript structure. Error bars represents ± standard error of the mean from 6–9 individual animals. Statistical significance was 
determined by using ANOVA analysis followed by Tukey post hoc test (*p < 0.05, **p < 0.01, ***p < 0.001). B. Relative inter-
strain differences in expression are presented as results from the multiple probe-sets measured by the MBEI method. Each 
probe was aligned with mRNA sequence and exon structure downloaded from Ensembl or GenBank databases. Image displays 
signal intensity from an individual array with emphasized mean value. Array probe-sets marked in red were found to be signifi-
cantly different between the four strains of mice. C. Genome-wide interval multiple mapping for six probe-sets (Atp1a2 – 
1455136_at, Kcnj9 – 1450712_at, Gabra2 – 1443865_at, Grm7 – 1459532_at, Gabra1 – 1436889_at, Comt – 1418701_at) in 
WebQTL (HBP/Rosen Striatum M430V2 (Apr05) PDNN Clean). The likelihood ratio statistics (LRS) score for association of 
the gene expression with genotype across genome of BXD recombinant strains for each probe-set is represented as coloured 
trace. Mouse chromosomes are plotted along y-axis, with the exception for chromosome Y. Coloured triangles indicate tran-
script locations. Cis-regulatory QTLs for Atp1a2 (1455136_at), Kcnj9 (1450712_at), Grm7 (1459532_at), Comt (1418701_at) are 
marked with black arrows.BMC Genomics 2006, 7:146 http://www.biomedcentral.com/1471-2164/7/146
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Comparison of basal gene expression between the selected inbred mouse strains, regulated by administration in the locus cer- uleus (LC) or ventral tegmental area (VTA) of the C57BL/6J mice [34] Figure 4
Comparison of basal gene expression between the selected inbred mouse strains, regulated by administration 
in the locus ceruleus (LC) or ventral tegmental area (VTA) of the C57BL/6J mice [34]. A. Cluster of genes whose 
expression was different according to array analysis. Coloured rectangles represent expression levels of the gene indicated on 
the right. Intensity of the colour is proportional to the fold change as indicated on the bar below the cluster image. The 
selected genes were previously found to be regulated by opioid administration as described on the right, after chronic mor-
phine administration (CM) and morphine withdrawal (MW), respectively. Directions of the changes are indicated by arrows: 
(↑) – up-regulation and (↓) – down-regulation. Relative expression levels were measured by MBEI method. B. Expression level 
of Gfap and Mtap2 in the striatum, obtained by microarray experiment. Putative short mRNA forms detected by microarray 
probe-sets (Gfap – 1440142_s_at, Mtap2 – 1440699_at) are presented below. The image displays signal intensity from individ-
ual array with emphasized mean value.
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Correlation between opioid-related phenotypes and striatal gene expression Figure 5
Correlation between opioid-related phenotypes and striatal gene expression. Comparison was performed using 
gene expression values of 1528 probe-sets significantly different between 129P3/J, DBA/2J, C57BL/6J and SWR/J strains [6]. 
Correlations between gene expression and morphine-related traits for RI BXD strains were computed using HBP/Rosen Stria-
tum M430 v2.0 (Apr05) PDNN Clean dataset [69, 70]. All analyses were evaluated using the Pearson's correlation. Probe-sets 
overlapped in both analyses are presented in two tables on the left and right. Presented below scatterplots of correlation 
between expression values of two genes (Khdrbs1 and Atp1a2) emphasized in the table by blue colour and phenotypic data 
were generated by using WebQTL.
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[38] and ethanol withdrawal [39] was shown previously.
A switch in subunit composition of GABA-A receptor in
the rat hippocampus was observed in withdrawal state
from chronic intermittent ethanol treatment, with a
decreased expression of alpha 1 subunit protein [40].
Gene expression of Gabra1 and Gabra2 subunits showed
opposite profiles in C57BL/6J and DBA/2J mice. The idea
that different subunits of GABA-A receptor are involved in
mediation of different actions of the receptor provides a
partial explanation of differences in morphine or ethanol
preference between C57BL and DBA. In addition, a previ-
ously performed Northern Blot study on the whole brain
tissue found no difference between those two strains [41],
which suggests specific distinction in distribution of those
transcripts in the striatum. Several lines of evidence sug-
gest that expression of GABA-A receptor alpha subunits
genes has a modulatory influence on the effects of mor-
phine, as well as on the action of other drugs of abuse
mediated by the endogenous opioid system. Catechol-O-
methyltransferase (Comt), an enzyme degrading catecho-
lamines, has been investigated as a candidate gene in
many neurological disorders. Variation of Comt gene tran-
script level in the hippocampus between eight inbred
mouse strains was found to be strongly correlated with the
aggression phenotype [21]. Our results for C57BL/6J and
DBA/2J are in agreement with previous observations,
though the other probe-set located in the deep 3' end of
transcript showed an opposite profile with high reverse
correlation. One can speculate that there exist two forms
of Comt mRNA different in length, corresponding to the
long and short forms of transcript which were found in
humans [42]. In humans, variability in the Comt gene
alters the analgesic potency of morphine, demonstrating
that genetic variability in non-opioid systems may indi-
rectly influence the clinical efficacy of morphine [43]. The
next interesting gene found in our research is the metabo-
tropic glutamate receptor 7, which has been suggested to
be associated with mediating aversive states and learning
[44]. Deletion of Grm7 gene in mice produces a selective
working memory impairment [45]. However, the differ-
ences observed in metabotropic glutamate receptor 7 gene
expression is more difficult to interpret due to the lack of
correlation between array and qPCR results. A difference
in mRNA level was also observed for synaptotagmin IV
(Syt4), a protein critical for such brain functions as learn-
ing, memory and motor coordination [46]. Two addi-
tional candidate genes: potassium inwardly-rectifying
channel subfamily J member 9 (Kcnj9) and ATPase Na+/
K+ transporting alpha 2 (Atp1a2) are located in the same
region of chromosome 1, which is the region of formerly
proposed quantitative trait loci (QTL) for basal locomotor
activity [36], ethanol sensitivity [47] and ethanol with-
drawal [48]. The G-protein-gated inwardly rectifying K+
channel is activated by many different substances, includ-
ing opioid receptor ligands. The neuronal potassium
channel subunit Kcnj9 knockout mice exhibited blunted
morphine-induced analgesia [32] and dramatically
reduced intravenous self-administration of cocaine [49].
The present results are in agreement with previous micro-
array data [20,36], and the differences in gene expression
were confirmed by qPCR method. Cis-acting variation
that caused lower expression in the C57BL strain results
from polymorphism in the 5'-UTR that disrupted the
binding of transcription factors [36]. Acute and chronic
morphine treatment was demonstrated to modulate Na+/
K+ ATPase activity in the mouse hippocampus [50]. Addi-
tionally, heterozygous Atp1a2 deficient mice showed aug-
mented fear and anxiety behaviours and enhanced
neuronal activity in the amygdala and piriform cortex
after conditioned fear stimuli [51]. Previous studies sug-
gested that differences in the opiate reward learning
between C57BL/6J and 129/SvJ were connected to differ-
ent anxiety level [52].
Interestingly, high reverse correlation among probe-sets
of the same transcript was found for Atp1a2 and Comt.
Inspection of hybridization profile within selected probe-
sets revealed that there were no noticeable abnormalities
suggesting a role of SNPs in the measurement of gene
expression. Furthermore, previously estimated SNP den-
sity has shown that only a small fraction of probes contain
SNPs that can affect hybridization efficiency [27,28,53].
Using mouse BLAT tool we did not identify other tran-
scripts with high sequence homology and specificity to
the probe-sets designed to detect mentioned genes. There-
fore, there is no evident indication of cross-hybridization.
In addition, the observed high negative correlation may
suggest detection of diverse mRNA forms. In addition, for
C57BL/6J and DBA/2J parental strains of BXD RI mouse
panel, our results are similar to those from WebQTL data-
base. To establish the source of these rather unexpected
results, we have applied the interval mapping tool from
the WebQTL database, which allowed for identification of
putative cis- and trans-acting elements controlling gene
expression. Differences in the signal of four genes (Atp1a2,
Kcnj9, Grm7, Comt) selected for further investigation were
found to be regulated by strong cis-acting elements. Cis-
acting regulation of expression results from DNA varia-
tions of a gene that directly influence mRNA level of that
gene [53]. This includes SNPs in the gene promoter region
which could affect efficiency of transcription. Similar pro-
file of results can be observed when inter-strain differ-
ences in abundance of alternative mRNA forms were
detected by arrays. As mentioned above, results of the
microarray experiment for the Atp1a2  and  Comt  tran-
scripts were not consistent. We observed that, qPCR meas-
urements were in agreement with microarray results if
signal was detected in the same region of the transcript.
However, general estimation of relationship between
microarray and qPCR techniques was difficult due toBMC Genomics 2006, 7:146 http://www.biomedcentral.com/1471-2164/7/146
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appearance of putative mRNA forms detected by Affyme-
trix arrays. Most of the probes on the Affymetrix micro-
array are complementary to parts of the last exons or the
3' untranslated region. Differences in 3' UTRs might speak
for the utilization of different signal sequences for tran-
scription termination or alternative polyadenylation. In
mice, alternative splicing was detected in 47% of genes,
alternative start site and alternative transcription termina-
tion was detected in 18% and 14% genes, respectively
[54]. A novel form of growth-arrest-specific transcript 5
(Gas5) that generate a shorter mRNA was found to be
more abundant in C57BL/6J compared to 129/SvEv strain
[25]. A difference in the expression of alternatively spliced
forms of transcripts of κ opioid receptor gene between
C57BL/6ByJ and BALB/cJ has been previously reported
[55]. Moreover, a strain-dependent variation in the
expression of alternatively spliced κ opioid receptor was
proposed as a significant source of phenotypic variation
of alcohol preference [55].
Using a combination of two independent analyses, we
identified genes whose mRNA levels are highly correlated
with preference to oral morphine self-administration and
morphine-induced analgesia. The analysis revealed strong
association between the level of mRNA for K homology
domain containing, RNA binding, signal transduction
associated 1 (Khdrbs1) and preference to morphine. The
product of Khdrbs1 mRNA translation RNA-binding pro-
tein was implicated in gene transcription, RNA splicing
and export, as well it was found to be involved in the
activity-dependent regulation of dendritic mRNAs [56].
Expression level of Gabra2 negatively correlated with oral
morphine consumption, providing another indirect evi-
dence for involvement of GABA-A receptor in the poly-
genic system influencing morphine preference.
Differences in Atp1a2 showed high correlation with phe-
notypic manifestation of morphine-induced analgesia
measured by the hot-plate assay. Additionally, the pre-
sented data indicate alternative termination of Atp1a2
transcript, with putative functional role of different tran-
script forms.
Comparison of genes that differentiate the strains of mice
with genes regulated by opioid administration in the
locus coeruleus (LC) or VTA of C57BL [34] showed poten-
tial associations between basal gene transcription and
expression profiles after morphine treatment and
naloxone-precipitated withdrawal. Inter-strain differences
in naïve mice were compared with 94 genes regulated after
chronic morphine treatment or after naloxone-precipi-
tated morphine withdrawal [34]. Genes represented by 16
probe-sets were overlapping (Figure 4). Naloxone-precip-
itated withdrawal induced expression of the heat shock
protein 1B (Hspa1b). High basal heat shock protein 1B
(Hsp1b) mRNA level in SWR strain may be connected with
its unusual sensitivity to naloxone-precipitated with-
drawal [9]. Induction of the heat shock protein 70
(Hsp1b) expression was also observed after chronic mor-
phine treatment in mice and rats [34,38,57], and had
been suggested to be associated with protection of the
nervous tissue against hazardous effects of opiates [58].
Two genes connected with cytoskeleton organisation, the
neuronal microtubule-associated protein 2 (Mtap2) and
astrocytic glial fibrillary acidic protein (Gfap) were identi-
fied. The marker of astrocytes and astroglial activation,
Gfap, was previously connected with morphine action
[33]. However, qPCR and detailed analysis of mRNA
sequence of Gfap and Mtap2 indicated that strain differ-
ences are limited to putative short transcript forms whose
functional significance is not known (Figure 4).
Our next task will be to estimate interactions between
genetic background and genomic response to morphine
in the four analysed inbred mouse strains. This approach
would continue to expand research on the relationship
between gene expression and specific opioid-related
behaviours.
Conclusion
Identification of entire gene networks and single genes
that underlie or modify susceptibility to morphine would
open new perspectives of pharmacological interventions.
Here, we suggest involvement of several new genes in
complex traits associated with opioid-related phenotype.
The present results suggest strong contribution of genetic
background to differences in gene expression. This obser-
vation is important for comparisons of gene expression
studies carried on different inbred strains and interpreta-
tion of results from experiments performed on knock-out
animals with mixed background. In summary, genomic
factors with potential ability to underlie differences in the
response to opioids are described in the presented paper.
The identified genes provide promising candidates for
future studies in animals and for translational genetic
studies in the field of addictive and analgesic properties of
opioids.
Methods
Tissue collection and RNA isolation
Adult male (8 to 10 weeks of age) 129P3/J (000690),
DBA/2J (000671), C57BL/6J (000664) and SWR/J
(000689) mice (The Jackson Laboratory, Bar Harbor,
Maine, USA) were housed 6 per a cage, under 12 h dark/
light cycle, with ad libitum access to food and water. Ani-
mals were familiarized with handling procedure for 5
days and sacrificed after the last session. All animals were
drug-naïve at the time of sacrifice. After decapitation,
brains were removed from the skulls and dissected rap-
idly. We collected samples containing rostral part of cau-
date/putamen plus the nucleus accumbens (referred to asBMC Genomics 2006, 7:146 http://www.biomedcentral.com/1471-2164/7/146
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the striatum). The samples were placed in individual
tubes with tissue storage reagent RNA later (Qiagen Inc.,
Valencia, CA, USA), frozen on dry ice and stored at -70°C
until RNA isolation. Samples were thawed at room tem-
perature and homogenized in 1 ml of Trizol reagent (Inv-
itrogen, Carlsbad, CA, USA). RNA isolation was
performed according to the manufacturer's protocol.
Quality of the total RNA was assessed by intensity of 28S
and 18S bands after agarose electrophoresis with Sybr-
Gold staining (Molecular Probes, Inc., Eugene, Oregon,
USA) and by spectrophotometric ratio A260/A280 (1.9–
2.1). RNA concentration was measured using the fluores-
cent reagent RiboGreen (Molecular Probes, Inc., Eugene,
Oregon, USA).
Microarray hybridization
The same amount of total RNA from three animals was
pooled, and further purified by using RNeasy Mini Kit
(Qiagen Inc., Valencia, CA, USA). For each array inde-
pendent pool of RNA from three animals was prepared.
Sample pooling was performed to decrease variation
within the group [59]. The quality of RNA was addition-
ally determined by using RNA 6000 Nano LabChip Kit
and Agilent Bioanalyzer 2100 (Agilent, Palo Alto, CA,
USA), and there was little evidence of degradation prod-
ucts in any of the total RNA samples. Preparation of cRNA
was performed according to the protocol provided by
Affymetrix. Total RNA (5 μg) derived from each pool was
converted to double-stranded cDNA using SuperScript
System (Invitrogen, Carlsbad, CA) and an oligo(dT24)
primer containing a T7 RNA polymerase promoter site
(Genset Oligos, La Jolla, CA). Biotin-labelled cRNA was
synthesized from cDNA using a BioArray High Yield RNA
Transcript labelling Kit (ENZO, Diagnostics, Farmingdale,
NY) and purified by using a GeneChip Cleanup Sample
Module (Qiagen Inc., Valencia, CA, USA). Each cRNA
sample was synthesized from independent biological
sample. The yield of the in vitro transcription reaction was
determined by product absorbance at 260 nm measured
by NanoDrop ND-1000 (NanoDrop Technologies, Inc.,
Montchanin, DE), size of cRNA probes was evaluated by
using RNA 6000 Nano LabChip Kit (Agilent, Palo Alto,
CA, USA). Following labelling, samples were hybridized
to the GeneChip Test3 array (Affymetrix, Santa Clara, CA)
for quality control. Fragmented cRNA (15 μg) was used
for hybridization to GeneChip Mouse Genome 430 2.0
arrays (Affymetrix, Santa Clara, CA). New generation of
Mouse Genome Genechips, with improved quality of
probes, was used to detect extended number of transcripts
(45.101 probe-sets). Arrays were washed and stained with
streptavidin-phycoerythrin (Merck, Darmstadt, Germany)
in Fluidic Station 400 (Affymetrix, Santa Clara, CA),
according to standard protocol of the manufacturer. The
arrays were scanned by using GeneChip Scanner 3000
(Affymetrix, Santa Clara, CA). Results were obtained from
arrays processed in two batches, in first batch 12 arrays
were hybridized (3 independent replicates per each strain)
and 8 in the second (2 independent replicates per strain).
All the arrays were run using a single protocol. Five chips
were prepared for each strain of mice.
Microarray data analysis
Microarray data was initially processed using GeneChip
Operating Software (GCOS, Affymetrix, Santa Clara, CA).
Chip quality was assessed using R 2.1.0 with simpleaffy
package [60,61]. Parameters such as scaling factor (0.64 ±
0.11), % of present call (51.7 ± 0.63) and 3'/5' degrada-
tion ratio (AFFX-GapdhMur/M32599 = 0.26 ± 0.22 and
AFFX-b-ActinMur/M12481 = 0.8 ± 0.23) were compared
according to Affymetrix guidelines. Raw data was normal-
ized by multiple available methods using R 2.1.0 with
Bioconductor with affy package, dChip 1.3 and Perfect-
Match 2.3.0.0 software [61-64]. For selected genes signal
from each probe was compared between all the arrays
with dChip software to identify indications of SNPs in the
region of probe-set hybridization. Full dataset with gene
expression values generated by PDNN algorithm are
included in additional material (see Additional file 1).
Gene ranking and filtering
Significance levels (p-values) of differences between the
four inbred strains were calculated for each probe-set
using analysis of variance [65] for three pre-processing
methods. In our opinion, traditional Bonferroni correc-
tion for multiple tests is too stringent for that kind of data-
set, and would lead to passing over of important results.
Therefore, false discovery rates (q-values) were calculated
for ANOVA significance levels using q-value package for R
[30]. For our purposes, we constructed a rank based on q-
value levels of three selected methods (RMA, PDNN,
MBEI). A probe-set scored 1, 2 or 3 points if it achieved
cut-off at q < 0.01, q < 0.001 or q < 0.0001, respectively,
for each of three methods. Every probe-set gets a rank
from 0 to 9, where 9 means that probe-set was highly sig-
nificant in all three normalization method, 3 means that
probe-set was medium significant in all three methods or
highly significant in only one method, 0 means that
probe-set reached significance level in none of the three
chosen methods (Figure 2). The proposed scheme, which
takes into consideration results of three methods, requires
a probe-set to be highly significant in one of the methods
or less significant but in each of the methods to be
selected for further analysis. The following criteria were
applied for probe-set detection: present call at least in
25% of PM/MM pairs and signal intensity >6.64 (log2
data) in at least 25% of arrays, both measured by dChip
software. Additionally, strain-specific differences in the
basal gene expression were selected by computing
between-strain contrast matrix for each probe-set using
unpaired t-test with expression values normalized byBMC Genomics 2006, 7:146 http://www.biomedcentral.com/1471-2164/7/146
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PDNN. Gene expression level was considered to be spe-
cific for a particular strain if it was significantly different
(p < 0.01) in all three contrasts given to the strain. To reli-
ably reveal difference in low abundant transcripts, analy-
ses were performed on five biological replicates of the
microarray. Hierarchical clustering and measurement of
relative expression levels were performed using dChip
software and MBEI algorithm [63].
Bioinformatic analysis of gene expression patterns
Gene sequences and exon structures were downloaded
from GenBank and Ensembl databases, and analyzed for
possible polymorphisms in the region covered by the
probe-sets. Direct probe mapping against publicly availa-
ble mRNAs/cDNA sequences was done by using mouse
BLAT tool for UCSC genome browser and ADAPT data-
base [66,67]. The Database for Annotation, Visualization
and Integrated Discovery (DAVID 2.1), a functional anno-
tation analysis tool, was used to identify over-represented
ontological groups among gene expression profiles and to
group genes into functional classifications [68]. Analyses
were performed at level five and with default parameters
which provide low coverage and relatively high specificity.
Over-represented GO terms were defined as having p ≤
0.01 under Fisher exact test. WebQTL database was used
to link gene expression to genetic markers and to detect
impact of regulatory variation [28].
Analysis of correlation between gene expression and 
phenotypes
Relations between the inter-strain differences in transcrip-
tional profile and two morphine-related traits were stud-
ied using correlation analysis. Results of voluntary
morphine consumption in two-bottle choice paradigm
(C57BL/6J = 134 mg/kg/day, 129P3/J = 24 mg/kg/day,
DBA/2J = 15 mg/kg/day and SWR/J = 6 mg/kg/day) pub-
lished by J. Belknap, 1993 [6] and analgesic effects of 3.6
mg/kg morphine in the hot-plate assay (129P3/J = 100%
MPE, DBA/2J = 82% MPE, SWR/J = 56% MPE and C57BL/
J6 = 7% MPE) estimated in our laboratory by W. Solecki
(Solecki et al., in preparation) were used in the analysis.
Correlations between the expression level from 1528
probe-sets (PDNN) and the phenotypic data was com-
puted using the Pearson's correlation. Probe-sets with r >
|0.95| and p < 0.05 were taken into further consideration.
Separate analysis of interactions with the both traits was
carried out using publicly available BXD IR strains data-
base (BXD Published Phenotypes Database). All correla-
tions were computed using HBP/Rosen Striatum M430
v2.0 (Apr05) PDNN Clean dataset. List of probe-sets with
r > |0.5| and significant correlation with trait ID 10029
(morphine analgesia in response to 16 mg/kg morphine,
hot-plate assay) and 10469 (morphine consumption-two
bottle choice) were downloaded using WebQTL scriptable
interface [69,70]. Analyses were determined using the
Pearson's correlation with default parameters, significant
correlation was found at p < 0.05. Lists of probe-sets with
significant results obtained separately using both
approaches were generated.
The list of genes regulated by opioid administration in the
LC and VTA of C57BL/6J mice was built based on supple-
mentary material published by McClung et al. [34].
Updated annotations for 94 probe-sets from the MG-
U74Av2 microarray were obtained from Affymetrix web-
site http://www.affymetrix.com.
Real-time PCR
Reverse transcription was performed with Omniscript RT
enzyme (Qiagen Inc., Valencia, CA, USA) at 37°C for 60
min. Reaction was carried out in the presence of RNAse
inhibitor (rRNAsin, Promega, USA), and oligo(dT16)
primer (Qiagen Inc., Valencia, CA, USA) was used to selec-
tively amplify mRNA. Quantitative real-time RT-PCR reac-
tions were performed using Assay-On-Demand Taqman
probes (details in Table 3, with the exception for Grm7
gene for which primers and probe were designed with
Primer3 software) according to the manufacturer's proto-
col (Applied Biosystems, Foster, CA, USA), and run on the
iCycler device (BioRad, Hercules, CA, USA) with the 3.0a
software version. For each reaction ~50 ng of cDNA syn-
thesized on total RNA template from individual animal
were used. Entire qPCR experiment was performed twice,
on samples used for array hybridization qPCR I (n = 6–9)
and on independent RNA samples qPCR II (n = 6). To
minimise the contribution of contaminating genomic
DNA primers were designed to span exon junctions. Addi-
tionally, control reactions without RT enzyme for each
assay were performed. Amplification efficiency for each
assay was determined by running a standard dilution
curve. Expression of hypoxanthine guanine phosphoribo-
syl transferase 1 (Hprt1) transcript with stable level
between four strains was quantified to control for varia-
tion in cDNA amounts. The cycle threshold values were
calculated automatically by iCycler IQ 3.0a software with
default parameters. Abundance of RNA was calculated as
2-(threshold cycle). Data was analyzed by one-way ANOVA fol-
lowed by Tukey post hoc test.
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